chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a physician via a company representative refers to a female patient of unkonwn age. Medical history and concurrent conditions were not reported. On an unkonwn date the patient was vaccinated with GARDASIL dose 1 and 2. Dose, route, lot number and expiration date were not reported. No co-suspect and concomitant therapies were reported. The physician reported that "the patient experienced syncope after receiving the first dose and seemed to be out of it for an hour after, receiving the second dose of GARDASIL". (on an unknown date). The outcome of seem to be out of it and syncope was unknown. The patient sought medical attention, Office visit on an unspecified date. Additional information has been requested.
Flushed face; Sudden heavy sweating; Sudden feeling of skin being hot especially in the back of neck; Sudden feeling of skin being hot especially in face.; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ewols8, expiration date: Jul2021) via an unspecified route of administration in the left arm on 11Apr2021 at 10:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was reported as none. The patient had no known allergies to medications, food, or other products. The patient did not receive any medication within two weeks of the vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 11Apr2021 at 10:15, the patient experienced a flushed face, sudden heavy sweating and sudden feeling of skin being hot especially in the back of neck and face. The events did not result in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with ice pack on neck and on top of head. The clinical outcome of the events flushed face, sudden heavy sweating and sudden feeling of skin being hot especially in the back of neck and face was recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
Information has been received from a consumer, a 73 year old female with no drug allergies, hypertension, high cholesterol and depression who on 06-AUG-2007 was vaccinated with a 0.65ml SC dose of Zostavax (Oka/Merck).  Concomitant therapy included trazodone HCl, PROCARDIA XL, CYMBALTA and ezetimibe (+) simvastatin (MSD).  On 08-AUG-2007 the patient developed a rash where she received the vaccine.  No medical attention was sought.  No diagnostic studies or labs were performed.  It was noted that the patient was not recovered.  There was no product quality complaint.  Additional information has been requested.
patient developed a red patch 2inces wide, 1 inch long which is itchy. asked patient to take benadryl  and  informed doctor. Followed up with patient and she said it went away  and patient is doing well.  Doctor also followed up with her in 24 hours over phone.
A week after the first vaccine I developed  swollen supraclavicular area s on the L side where the first Pfizer Covid vaccine was administered.  3 weeks later for the 2nd vaccine I had it administered on the R arm and subsequently developed enlarged supraclavicular swelling on R side as well. I currently still have significant swelling now bilateral supraclavicular areas
Pfizer COVID-19 Vaccine EUA  Patient experienced swelling of the tongue around 7 hrs after vaccination.  Patient took oral prednisone and swelling resolved.
Initial report received from a health care professional on 09 December 2010. A female patient (age not reported) received on 12 October 2010 an intramuscular injection (site not reported) of FLUZONE SV 2010-2011, lot number UH184AA. The patient's medical history and concomitant medications were unknown. The patient had no illness at the time of vaccination and received no other vaccines within 4 weeks. On an unknown date but after the vaccination was administered, the patient developed dizziness, headache, numbness and tingling in all extremities, severe generalized weakness to the point of being bed ridden and needing assistance with care. The patient was seen in the emergency room and also by her physician. She had cardiac studies and a computed tomography (CT) scan of the brain which were negative. The patient was scheduled for a magnetic resonance imaging (MRI) scan and neurology consult. The patient had only a slight improvement. The outcome was reported as not recovered. Documents held by sender: None.
Sore injection site a few hours after shot, headache. The next day entire arm was sore and migraine, zero energy. A week later, itchy red spot that has turned into a ring
thought I was going to die; sick / thought I was going to die.; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received the 1st dose of Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced sickness and impending doom. On an unknown date, the outcome of the sickness was recovered/resolved and the outcome of the impending doom was unknown.   It was unknown if the reporter considered the sickness and impending doom to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The age at vaccination was not reported. After receiving Influenza vaccine, the patient was so sick for 2 weeks thought he/she was going to die.
There has not been any adverse reaction noted at this time. VAERS is being filed because child received DTaP instead of Tdap. He is 8 years old and just starting the tetanus containing vaccine series. Measures have been implemented to avoid this error in the future. Vaccine dose will count as first dose of tetanus containing vaccine.
get shakes; giant headache / thought that her head was going to explode / headache was concentrated above her right ear; This case was reported by a consumer via call center representative and described the occurrence of headache in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 30th September 2020, the patient received the 1st dose of Shingrix. On 30th September 2020, less than a day after receiving Shingrix, the patient experienced headache and tremor. The patient was treated with antimigraine preparations (Migraine Cocktail (Nos)). On an unknown date, the outcome of the headache was recovered/resolved and the outcome of the tremor was unknown.   It was unknown if the reporter considered the headache and tremor to be related to Shingrix.  Additional details were provided as follows: The patient received the Shingrix on 30th September 2020 and around 6 pm that day she started to get shakes and a giant headache. The patient thought that her head was going to explode and the headache lasted for 13 days. The patient was referred to the emergency room by her physician and they administered a COVID test and CT scan which was normal. They administered the patient a headache cocktail through  intravenous and it had no effect on the headache until she reached day 13. The headache was concentrated above her right ear. The reporter consented to follow up.
Developed Bell?s Palsy 3 1/2 weeks after vaccination.  Developed peripheral neuropathy hands/feet 4 weeks after  Hypertensive crisis (No Hx of high BP)
Pt in office 08/24/04 with 6x6cm reddened area on left upper arm, no induration noted at injection site, no warmth.
pt recv vax & exp swollen feet & hands & hives over the body;taken to ER but not admitted;tx w/epi, cortisone & DPH;
No adverse effects were reported; the patient was inadvertently administered an expired dose of PNEUMOVAX 23; This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. Information about pertinent medical history, drug reactions/allergies and concomitant medication was not provided.  On 15-OCT-2019, the patient was was inadvertently administered an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (vaccine dosage detail was not reported, lot # N022303, expiration date 01-MAR-2019) intramuscularly for prophylaxis (expired product administered). No temperature excursion. No adverse effects were reported.
The 54.5 year old male pt developed vertigo and vomiting. After brain tumor surgery 8 week coma with meningitis, stroke sepsis, respiratory and kidney failure, permanent residuals-gait ataxia, peripheral nerve damage, bronchiectasis with ehmophysis episodes, speech and swallowing difficulties, hypotension after meals, hearing and vision damage. Per follow up letter pt did not recover. Galt ataxia, chronic bronchitis, partial swallowing paralysis. Very disapponited in how my original report was handled. The interviewer was either blindly bias or severly handicapped by lack of training as an interviewer. This is being made just in case the VAERS program is not the sham it appears to be. From top to bottom, CDC and HHS should be overlooked so as not to appear to be anothe PAC for the pharmaceutical industry.
Psychosomatic response after flu vaccination -> syncope. Supportive care. EMT services called.
Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness). At the time of the report, PAIN IN EXTREMITY (Arm soreness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        Concomitant medications were not reported. No treatment information was provided.    This case was linked to MOD-2021-036614 (Patient Link).
This spontaneous report as received from a registered nurse (R.N.) refers to multiple unspecified patients of unknown age and gender. The patients; medical history, concurrent conditions and concomitant medications were not provided. On unspecified dates, the patients were vaccinated with an improperly stored doses of PROQUAD (Merck) lot # L047305, expiration date: 23-MAY-2017 (dose and route of administration were not specified). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Pt recvd 1 dose of Engerix-B & the same day exp redness, discomfort, extreme swelling & light-headedness;
This is approximately 48 hours after injection, she is experiencing redness & swelling at injection site.
Information has been received from a consumer concerning her daughter who in 2008 (reported as "3 years ago"), was vaccinated with the 3 series of GARDASIL (lot#s not reported). It was reported that "they recently moved" and she took her daughter to a new doctor who gave her daughter another dose of GARDASIL (lot# not reported) shot recently in approximately April 2011 without parental consent. After receiving the shot her daughter became very agitated, belligerent, she was screaming out of her character and she was distraught. The next day she was very tired and at the injection site it was very "nasty" looking and bruised. At the time of reporting, the outcome of the events was not reported. The patient did not seek medical attention. No further information is available.
Patient states he had his 1st pfizer vaccine in March and did not tolerate this well.  He discussed with his doctor  and would like to proceed with the J&J vaccine at this time.
Fever,; Body aches; Headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EWO179) via an unspecified route of administration in the left arm on 12May2021 at 10:15 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included vitiligo, eczema and IBS (irritable bowel syndrome). The patient did not have any allergies to medications, food, or other products. The patient received unspecified concomitant medications within 2 weeks of the vaccination. The patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EWO170) via an unspecified route of administration in the left arm on 21Apr2021 at 09:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 12May2021 at 22:30, 12 hours after the shot was given, the patient experienced fever, body aches, headache and fatigue. No therapeutic measures were taken for the reported events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever, body aches, headache and fatigue were recovering.  No follow-up attempts are needed. No further information is expected.
Patient developed fast heart rate, chest pain - seen by PMD who admitted patient to hospital cardiac scan showed Myocarditis. Symptoms started 5/1/21
Administration Error: Patient received the Moderna COVID-19 vaccine for her primary series and came in for her booster appointment. She was okay with receiving any vaccine as a booster and was registered & sent to the Janssen lane for her booster. However, the vaccinator accidentally administered the Pfizer booster instead of Janssen. The vaccinator informed his lead of the error. Patient was informed by the pharmacist about the error and addressed all her questions and concerns. Patient mentioned that she was fine with the Pfizer booster vaccine. Her card and online record were accurately updated to reflect the Pfizer booster that was given.
Rash all over my stomach and groin plus diarrhea; Rash all over my stomach and groin plus diarrhea; This is a spontaneous report from a contactable consumer or other non hcp. A 39-year-old non-pregnant female patient received bnt162b2 (BNT162B2, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Right on 29Jun2021 17:45 (Vaccination at the age of 39 years) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included covid-19 (covid prior vaccination: Yes) from an unknown date and Known allergies: No. No other vaccine in four weeks. Had covid prior vaccination and covid not tested post vaccination. The patient experienced rash all over my stomach and groin plus diarrhea on 01Jul2021 10:00. Outcome of the events was unknown.  Information about lot/batch number has been requested.
Patient received Covid 19 Pfizer booster shot. After receiving vaccine; patient waited 15 minutes and reported no reaction. Two Days later, patient calls reporting of arm pain. counseled pt this is common reaction for vaccination and how to treat the reaction. Informed pt to follow up with if continue to have pain. followed up with pt on 10/27/21 to see if reaction is still happening. Pt informed she still has small injection site pain, no redness, and small warm to touch. Patient reports no fever, but just fatigue. Patient reports pain has decreased. Counseled pt again how to treat symptoms and to follow up with pcp if symptoms worsen.
high fever 8 hrs p/vax 104.5 R parent witnessed generalized shaking of 4 limbs x 45 sec; sz activity; no abnormalities on exam;
Pt stated right arm was swollen over 3 inches, red (sunburn looking), and painful. Recommended patient to apply ice and take BENADRYL. Report back later today. Reaction started next morning after receiving vaccine.
This initial spontaneous case, was received on 16-Oct-2017, from Pharmacist, concerning a female patient of an unspecified age. On 16-Oct-2017, the patient was administered with AFLURIA (dose: (reported as less than 0.5 ml), route of administration: intramuscular, anatomical location, batch number: XT34208, expiry date: Jun-2018). It was reported that, the nurse who had administered the vaccine to the patient had not kept the needle correctly when she went for administration and therefore, some of the vaccine ran down on the arm of the nurse. As a result, complete dose was not administered to the patient which was characterized to partial dose was administered. The patient did not experience any adverse event. The outcome of the events was not reported. The reporter assessed the case as non-serious. Follow up received from pharmacist on 25-Oct-2017: Added patient details (gender), suspect vaccine details (start date, route, batch number and expiry date), event (no adverse event). Narrative amended accordingly.
brachial plexis neuropathy which resembled herpes zoster w/o the lesions; 4 of 6 rpt from same provider; 9DEC93 No response to f/u request;
One week after Pfizer vaccine, I started having tingling in my lower legs and feet. Weeks later it continues and also includes tingling in hands.
Muscle pain 2 week after injection pt. did not seek treatment because she does not have insurance.
SKIN DISORDER/ARMS AND LEGS HAD BUMPS; This spontaneous report received from a patient concerned a 28 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies, had not taken any concomitant drugs and had no relevant medical history. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 23-JUN-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. Concomitant medications included risankizumab for moderate to severe chronic plaque psoriasis. On 30-JUN-2021, the subject experienced skin disorder/arms and legs had bumps. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from skin disorder/arms and legs had bumps. This report was non-serious.
ADMINISTRATION OF EXPIRED VACCINE; This spontaneous report received from a health care professional concerned multiple patients.  No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609 expiry: 1-JUN-2021) dose was not reported, administered on JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On JUN-2021, the subject experienced administration of expired vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of expired vaccine was not reported. This report was non-serious.
Blurred vision and Conjunctivitis in left eye beginning the day after the vaccine. I had no symptoms the day or week before and had not been anywhere to come in contact with the conjunctivitis.
Full body rash; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 8 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 13Nov2021 12:00 (Lot number: FK5127) at the age of 8 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: VYVANSE; GUANFACINE; DEXTROAMPHETAMINE HYDROCHLORIDE. The following information was reported: RASH (non-serious) with onset Nov2021, outcome "not recovered", described as "Full body rash". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of rash.  Follow-Up (29Dec2021): Follow-up attempts are completed. No further information is expected.
nausea; stomach pain; dry heaving; feel arm pain and was unable to lift my arm and move it normally; feel arm pain and was unable to lift my arm and move it normally; felt very fatigued and tired; a minor headache; This is a spontaneous report from a non-contactable consumer or other non hcp (patient, self-reporting). A 21-years-old female (non-pregnant) patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number and expiration dates were not reported), via an unspecified route of administration in arm left on 04Mar2021 at 08:00 as 1ST dose, single for COVID-19 immunisation. It was reported that the patient had no allergies, Patient Medical history and concomitant were not reported. The patient did not receive any other vaccine in four weeks and no other medications the patient received within 2 weeks of vaccination. Prior to vaccination patient was not diagnosed with COVID. Post vaccination patient did not test for COVID. It was reported that on 04Mar2021 at 13:00 several hours after the 1st dose, began to feel arm pain and was unable to lift her arm and move it normally. That evening, felt very fatigued and tired with a minor headache. Exactly 48 hours after the vaccine, she developed nausea and stomach pain that resulted in dry heaving for approximately 3-4 hours. No treatment was received for the events. Facility where the most recent COVID-19 vaccine administered was public health clinic/Veterans Administration facility. On an unspecified date, patient was recovered in the year of 2021.   No follow-up attempts are possible. No further information is expected.